Literature DB >> 25767285

Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

John E Hall1, Jussara M do Carmo2, Alexandre A da Silva2, Zhen Wang2, Michael E Hall2.   

Abstract

Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension, accounting for 65% to 75% of the risk for human primary (essential) hypertension. Increased renal tubular sodium reabsorption impairs pressure natriuresis and plays an important role in initiating obesity hypertension. The mediators of abnormal kidney function and increased blood pressure during development of obesity hypertension include (1) physical compression of the kidneys by fat in and around the kidneys, (2) activation of the renin-angiotensin-aldosterone system, and (3) increased sympathetic nervous system activity. Activation of the renin-angiotensin-aldosterone system is likely due, in part, to renal compression, as well as sympathetic nervous system activation. However, obesity also causes mineralocorticoid receptor activation independent of aldosterone or angiotensin II. The mechanisms for sympathetic nervous system activation in obesity have not been fully elucidated but may require leptin and activation of the brain melanocortin system. With prolonged obesity and development of target organ injury, especially renal injury, obesity-associated hypertension becomes more difficult to control, often requiring multiple antihypertensive drugs and treatment of other risk factors, including dyslipidemia, insulin resistance and diabetes mellitus, and inflammation. Unless effective antiobesity drugs are developed, the effect of obesity on hypertension and related cardiovascular, renal and metabolic disorders is likely to become even more important in the future as the prevalence of obesity continues to increase.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; chronic renal insufficiency; kidney; leptin; melanocortins; mineralocorticoids

Mesh:

Substances:

Year:  2015        PMID: 25767285      PMCID: PMC4363087          DOI: 10.1161/CIRCRESAHA.116.305697

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  140 in total

1.  Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events.

Authors:  Haroon L Chughtai; Timothy M Morgan; Michael Rocco; Brandon Stacey; Tina E Brinkley; Jingzhong Ding; Barbara Nicklas; Craig Hamilton; W Gregory Hundley
Journal:  Hypertension       Date:  2010-09-13       Impact factor: 10.190

2.  Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure.

Authors:  Peng Li; Bai-Ping Cui; Ling-Li Zhang; Hai-Jian Sun; Tong-Yan Liu; Guo-Qing Zhu
Journal:  Exp Physiol       Date:  2012-08-07       Impact factor: 2.969

Review 3.  Role of leptin and central nervous system melanocortins in obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John E Hall
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

4.  Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population.

Authors:  James O Burton; Laura J Gray; David R Webb; Melanie J Davies; Kamlesh Khunti; Winston Crasto; Sue J Carr; Nigel J Brunskill
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

5.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

6.  Distribution of renal medullary hyaluronan in lean and obese rabbits.

Authors:  T M Dwyer; S A Banks; M Alonso-Galicia; K Cockrell; J F Carroll; S A Bigler; J E Hall
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

7.  Role of selective leptin resistance in diet-induced obesity hypertension.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Allyn L Mark; William G Haynes
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

Review 8.  Hyperaldosteronism as a common cause of resistant hypertension.

Authors:  David A Calhoun
Journal:  Annu Rev Med       Date:  2012-10-22       Impact factor: 13.739

9.  Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation.

Authors:  Qian Gao; Michael J Wolfgang; Susanne Neschen; Katsutaro Morino; Tamas L Horvath; Gerald I Shulman; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

10.  Increased hyaluronic acid in the inner renal medulla of obese dogs.

Authors:  M Alonso-Galicia; T M Dwyer; G A Herrera; J E Hall
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

View more
  306 in total

Review 1.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

2.  Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study.

Authors:  Yuichiro Yano; Wanpen Vongpatanasin; Colby Ayers; Aslan Turer; Alvin Chandra; Mercedes R Carnethon; Philip Greenland; James A de Lemos; Ian J Neeland
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis.

Authors:  J Choi; S Park; T K Kwon; S I Sohn; K M Park; J I Kim
Journal:  Int J Obes (Lond)       Date:  2017-07-19       Impact factor: 5.095

4.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

Review 5.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

Review 6.  Leptin as a Mediator of Obesity-Induced Hypertension.

Authors:  Balyssa B Bell; Kamal Rahmouni
Journal:  Curr Obes Rep       Date:  2016-12

7.  Time Course of Blood Pressure Decrease After Bariatric Surgery in Normotensive and Hypertensive Patients.

Authors:  Devon N Hawkins; Byron J Faler; Yong U Choi; Balakrishna M Prasad
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

Review 8.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 9.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 10.  Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.

Authors:  Curt D Sigmund; Robert M Carey; Lawrence J Appel; Donna K Arnett; Hayden B Bosworth; William C Cushman; Zorina S Galis; Melissa Green Parker; John E Hall; David G Harrison; Alicia A McDonough; Holly L Nicastro; Suzanne Oparil; John W Osborn; Mohan K Raizada; Jacqueline D Wright; Young S Oh
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.